Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Successful Due Diligence Ends – $20M Placement To Proceed

by admin August 25, 2025
August 25, 2025
Successful Due Diligence Ends – $20M Placement To Proceed

Galan Lithium (GLN:AU) has announced Successful Due Diligence Ends – $20m Placement To Proceed

Download the PDF here.

This post appeared first on investingnews.com

previous post
Galan Lithium Limited: SUCCESSFUL DUE DILIGENCE COMPLETED – $20M PLACEMENT TO PROCEED
next post
Drilling Commences at Mt Hope Project

Related Posts

Peter Grandich: Gold Miners Set to Print Cash...

February 13, 2025

Finlay Minerals Announces Closing of Non-Brokered Private Placement...

June 10, 2025

Editor’s Picks: Gold Price Passes US$2,950, Trump Promises...

February 23, 2025

Bold Ventures

June 14, 2025

Ontario Tables Sweeping Bill to Restrict Foreign Access...

May 3, 2025

Ericsson, Rogers Launch Canada’s First Underground 5G Network...

June 21, 2025

Albemarle Swings to Profit, Lowers Spending Amid Prolonged...

August 2, 2025

Prismo Metals to Advance Hot Breccia Toward Drilling...

February 27, 2026

1911 Gold: Near-term Gold Production, Development Potential in...

February 14, 2025

Commencement of Henbury Field Program

September 1, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved